Skip to main content
SLU publication database (SLUpub)

Patent2023

Use of inosine for the treatment of t-reg deficiency

Roos, Stefan; Liu, Yuying; He, Baokun; Rhoads, Jon Marc

Abstract

The present invention provides the use of inosine in the treatment of a disease associated with Treg deficiency or Treg dysfunction, in particular immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX). In one embodiment of the invention, the inosine can be provided in the form of a bacterial strain that is capable of stimulating the production of inosine. Methods for stimulating the production of inosine in a subject using said strains are also provided, as are methods for the selection of a bacterial strain capable of stimulating inosine production in a subject.

Application number: US16/304,747
Patent number: US11602551B2
Application published date: 2021-03-04
Publication date: 2023-03-14

    UKÄ Subject classification

    Microbiology in the medical area

    More information

    Assignees: Biogaia AB and Board of Regents of the University of Texas System

    Permanent link to this page (URI)

    https://res.slu.se/id/publ/126735